Saturday, 5 September 2026European Markets

TELEPERFORMANCE And ELIS Have A High Dividend Yield And Return On Equity In The Specialty Business Services Industry.

Loading stream...

(vianews) - teleperformance (tep.pa) is among this list of stock assets with the highest dividend rate and return on equity on the specialty business services industry.

financial asset price forward dividend yield return on equity
teleperformance (tep.pa) €112.50 2.92% 17.54%
elis (elis.pa) €21.12 1.94% 9.02%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. teleperformance (tep.pa)

2.92% forward dividend yield and 17.54% return on equity

teleperformance se, together with its subsidiaries, engages in the provision of outsourced customer and citizen experience management, and related services in france and internationally. the company operates in two segments, core services and digital integrated business services, and specialized services. the core services and digital integrated business services segment offers customer and citizen care; customer relationship operations; technical support; and technical assistance and customer acquisition services, as well as back-office solutions and integrated services, including social media content moderation services and data labeling for automation solutions; and knowledge services in the field of analytics solutions, automated systems, and artificial intelligence. the company also manages business processes, as well as provides digital platform, consulting, and data analysis services; and business process outsourcing services for government agencies. the specialized services segment provides on-line interpretation, visa application management, health management services, and accounts receivable credit management services. it also offers digital recruitment process outsourcing; consumer health management business services and related digital solutions integration; translation and interpreting services; and business process outsourcing services for government agencies in the united states. the company serves automotive, energy and utilities, insurance, public sector, technology, travel and hospitality, and banking and financial services, as well as healthcare, media, retail and e-commerce, crypto, cargo, telecom, and video games industries. teleperformance se was incorporated in 1989 and is headquartered in paris, france.

earnings per share

as for profitability, teleperformance has a trailing twelve months eps of €10.82.

pe ratio

teleperformance has a trailing twelve months price to earnings ratio of 10.4. meaning, the purchaser of the share is investing €10.4 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 17.54%.

revenue growth

year-on-year quarterly revenue growth grew by 0.4%, now sitting on 8.17b for the twelve trailing months.

volume

today's last reported volume for teleperformance is 184469 which is 20.22% below its average volume of 231229.

dividend yield

according to morningstar, inc., the next dividend payment is on apr 21, 2023, the estimated forward annual dividend rate is 3.85 and the estimated forward annual dividend yield is 2.92%.

volatility

teleperformance's last week, last month's, and last quarter's current intraday variation average was a negative 4.82%, a negative 1.36%, and a positive 2.15%.

teleperformance's highest amplitude of average volatility was 5.02% (last week), 1.98% (last month), and 2.15% (last quarter).

more news about teleperformance.

2. elis (elis.pa)

1.94% forward dividend yield and 9.02% return on equity

elis sa provides flat linen, workwear, and hygiene and well-being solutions in france, central europe, scandinavia, eastern europe, the united kingdom, ireland, latin america, southern europe, and internationally. the company offers table, bed, kitchen, patient, and bath linens; workwear and personal protective equipment; beverage solutions, such as water coolers and accessories, cups and bottles, and coffee machines; floor protection mats and mops; industrial wipers; and pest and rodent control, insect control, or disinfection services. it also provides washroom hygiene services, such as hand washing and drying, toilet hygiene and urinals, lavatories, and air fragrancing; and reusable cleanroom garments, footwear, goggles, and related contamination control solutions, as well as cleaning systems. in addition, the company offers various solutions for collection and disposal of infectious waste, as well as laundry facilities. it primarily serves the catering, accommodation, healthcare and social welfare, industries, trade and retail, and services sectors, as well as public authorities and administration. elis sa was founded in 1883 and is headquartered in saint-cloud, france.

earnings per share

as for profitability, elis has a trailing twelve months eps of €1.2.

pe ratio

elis has a trailing twelve months price to earnings ratio of 17.6. meaning, the purchaser of the share is investing €17.6 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 9.02%.

more news about elis.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
AI Capital Surge Meets Investor Caution: Record Funding Rounds and Government Contracts Amid Valuation Skepticism
A single-week cluster of large AI/fintech funding rounds (Socure, Stability AI, Emerald AI, Generalist AI, Instinct, Gatik, Regent Craft) shows venture capital still pouring into AI infrastructure, identity, and autonomy plays, while Palantir's Army TITAN contract win coincided with a 6% stock drop — signaling that even flagship AI-defense revenue isn't immune to market reassessment of AI valuations. Efficiency-focused innovations like Multiverse Computing's model compression suggest the sector is also pivoting toward cost/inference economics as capital intensity draws scrutiny.
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Morgan Stanley & Co. LLC
The same metric (eps) for the same entity (Morgan Stanley & Co. LLC) reported for the identical fiscal period (Q1 2026) and observation date (2026-03-31) has two conflicting values: 3.43 USD_per_share vs 3.08 USD. This is not a temporal change — both observations claim to measure the same point in time. The ~10% discrepancy (0.35 USD difference) is material for a financial metric.
We flag conflicts openly ›
Recently verified
Checked against the original source
4,981
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,981 facts checked against source5,273 source documents archived
Query this data → isubstrate.com